Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Smartwatch Algorithm Detects Cardiac Arrest

By HospiMedica International staff writers
Posted on 04 Mar 2025

Out-of-hospital cardiac arrest is a critical emergency that demands immediate recognition and response; in cases of sudden, unwitnessed cardiac arrest, survival chances are extremely low. One of the key indicators of cardiac arrest is the sudden loss of a pulse. The use of automated biosensors to detect unwitnessed cardiac arrest and prompt medical assistance could significantly improve survival rates, given the critical role of time in determining outcomes. However, for such systems to be effective, minimizing the false positive burden on emergency medical services is essential. Researchers have now developed an artificial intelligence (AI) system for a smartwatch that can detect signs of cardiac arrest and automatically alert emergency responders. This machine-learning algorithm, partially trained on data from patients whose hearts were intentionally stopped during medical procedures, is capable of recognizing the key indicators of cardiac arrest. While the researchers believe this system could potentially save lives, further testing is necessary to confirm its effectiveness.

The smartwatch algorithm, which leverages machine learning, was developed by Google Research (Mountain View, CA, USA), and is designed to meet performance standards suitable for large-scale use. The researchers first utilized photoplethysmography (PPG) to demonstrate that PPG measurements of peripheral pulselessness (induced by an arterial occlusion model) mirror the signal pattern of pulselessness seen in ventricular fibrillation (VF), a common arrhythmia associated with cardiac arrest. By analyzing the similarity between the PPG signals from VF and those from the occlusion model, they developed and validated a pulse loss detection algorithm using data collected from both the simulated model and real-world conditions.

Once the algorithm was developed, the researchers tested it in real-world scenarios. The results, published in Nature, showed that the system generated one unintentional emergency call per 21.67 user-years across two prospective studies. The algorithm’s sensitivity was 67.23% (with a 95% confidence interval of 64.32%–70.05%) when tested in a simulated arterial occlusion model of cardiac arrest. These findings indicate that this new technology offers a promising solution for wearable detection of sudden pulse loss while minimizing the societal impact of false alarms.

Gold Member
12-Channel ECG
CM1200B
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Pediatric Phlebotomy Chair
2665M2 Extra Wide Pediatric Phlebotomy Chair
New
4K-3D NIR/ICG Video Endoscope
TIPCAM 1 Rubina
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get complete access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The Trilogy Valve with locator technology is the only TAVI system approved for aortic regurgitation (Photo courtesy of JenaValve)

New Transcatheter Valve Found Safe and Effective for Treating Aortic Regurgitation

Aortic regurgitation is a condition in which the aortic valve does not close properly, allowing blood to flow backward into the left ventricle. This results in decreased blood flow from the heart to the... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.